Welcome to LookChem.com Sign In|Join Free
  • or
p-tolyl-(tetra-O-acetyl-α-D-galactopyranoside) is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

34246-18-9

Post Buying Request

34246-18-9 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

34246-18-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 34246-18-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,4,2,4 and 6 respectively; the second part has 2 digits, 1 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 34246-18:
(7*3)+(6*4)+(5*2)+(4*4)+(3*6)+(2*1)+(1*8)=99
99 % 10 = 9
So 34246-18-9 is a valid CAS Registry Number.

34246-18-9Relevant academic research and scientific papers

Gold catalysis in glycosylation reactions

G?tze, Sebastian,Fitzner, Roland,Kunz, Horst

, p. 3346 - 3348 (2009)

Glycosylation of alcohols containing acid-sensitive groups, as for example 1,2-5,6-di-O-isopropylidene-glucofuranose, Fmoc-threonine tert-butyl ester or farnesol, is achieved using gly-cosyl trichloroacetimidates activated by gold(I) chloride (5-10 mol%). While glycosylation with 2-O-acyl protected glycosyl donors proceeds with 1,2-trans-selectivity, non-neighboring group active glycosyldonors give mixtures of anomeric glycosides or -glycosides depending upon their structure and the reactivity of the glycosyl acceptor. Georg Thieme Verlag Stuttgart New York.

Mechanistic evaluation of MelA α-galactosidase from citrobacter freundii: A family 4 glycosyl hydrolase in which oxidation is rate-limiting

Chakladar, Saswati,Cheng, Lydia,Choi, Mary,Liu, James,Bennet, Andrew J.

experimental part, p. 4298 - 4308 (2012/03/22)

The MelA gene from Citrobacter freundii, which encodes a glycosyl hydrolase family 4 (GH4) α-galactosidase, has been cloned and expressed in Escherichia coli. The recombinant enzyme catalyzes the hydrolysis of phenyl α-galactosides via a redox elimination-addition mechanism involving oxidation of the hydroxyl group at C-3 and elimination of phenol across the C-1-C-2 bond to give an enzyme-bound glycal intermediate. For optimal activity, the MelA enzyme requires two cofactors, NAD+ and Mn2+, and the addition of a reducing agent, such as mercaptoethanol. To delineate the mechanism of action for this GH4 enzyme, we measured leaving group effects, and the derived βlg values on V and V/K are indistinguishable from zero (-0.01 ± 0.02 and 0.02 ± 0.04, respectively). Deuterium kinetic isotope effects (KIEs) were measured for the weakly activated substrate phenyl α-d-galactopyranoside in which isotopic substitution was incorporated at C-1, C-2, or C-3. KIEs of 1.06 ± 0.07, 0.91 ± 0.04, and 1.02 ± 0.06 were measured on V for the 1-2H, 2- 2H, and 3-2H isotopic substrates, respectively. The corresponding values on V/K were 1.13 ± 0.07, 1.74 ± 0.06, and 1.74 ± 0.05, respectively. To determine if the KIEs report on a single step or on a virtual transition state, we measured KIEs using doubly deuterated substrates. The measured DV/K KIEs for MelA-catalyzed hydrolysis of phenyl α-d-galactopyranoside on the dideuterated substrates, DV/K(3-D)/(2-D,3-D) and DV/K (2-D)/(2-D,3-D), are 1.71 ± 0.12 and 1.71 ± 0.13, respectively. In addition, the corresponding values on V, DV (3-D)/(2-D,3-D) and DV(2-D)/(2-D,3-D), are 0.91 ± 0.06 and 1.01 ± 0.06, respectively. These observations are consistent with oxidation at C-3, which occurs via the transfer of a hydride to the on-board NAD+, being concerted with proton removal at C-2 and the fact that this step is the first irreversible step for the MelA α-galactosidase-catalyzed reactions of aryl substrates. In addition, the rate-limiting step for Vmax must come after this irreversible step in the reaction mechanism.

Glycosylated prodrugs, their method of preparation and their uses

-

, (2008/06/13)

Glycosylated prodrugs, a preparation method therefor, and their use with tumor-specific immunoenzymatic conjugates for the treatment of cancer, are described. These anthracycline prodrugs have formula (I). STR1

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 34246-18-9